• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bioavailability of controlled-release metoclopramide. 1st communication: single dose study.

作者信息

Beckett A H, Behrendt W A, Hadzija B W

出版信息

Arzneimittelforschung. 1987 Feb;37(2):221-4.

PMID:3580026
Abstract

The bioavailability of metoclopramide monochloride hydrate after single dose oral administration of a controlled-release capsule (Gastro-Timelets) was compared with that of oral metoclopramide monochloride hydrate solution in four normal volunteers. 30 mg of each product was administered to each subject in a cross-over manner on two separate occasions and plasma metoclopramide levels were measured using a HPLC method. Although peak plasma metoclopramide concentrations were lower, and occurred later after capsule treatment than after solution, analysis of the area under the plasma concentration-time curve (AUC) values for the two formulations demonstrated that the products were equivalent in terms of the extent of absorption, with the mean AUC value (0-30 h) for the capsule 943.7 ng/h/ml and that for the solution 896.2 ng/h/ml.

摘要

相似文献

1
Bioavailability of controlled-release metoclopramide. 1st communication: single dose study.
Arzneimittelforschung. 1987 Feb;37(2):221-4.
2
Bioavailability of controlled-release metoclopramide. 2nd communication: multiple dose study.
Arzneimittelforschung. 1987 Feb;37(2):224-8.
3
Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.健康志愿者单次口服给药后美托洛尔控释制剂与比索洛尔普通释放片的相对生物利用度
Int J Clin Pharmacol Ther. 1996 Feb;34(2):61-70.
4
In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.健康志愿者中,来自双峰释放制剂的哌甲酯的体外溶出和体内口服吸收情况。
Biopharm Drug Dispos. 2004 Mar;25(2):91-8. doi: 10.1002/bdd.390.
5
[Bioavailability of metoclopramide in a sustained-release preparation].
Arzneimittelforschung. 1984;34(5):637-9.
6
Bioavailability and pharmacokinetics of rectally administered metoclopramide.
Arzneimittelforschung. 1990 Jun;40(6):679-83.
7
Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.剂量对速释和缓释制剂中苯妥英生物利用度的影响:单剂量研究。
J Med Assoc Thai. 2007 Sep;90(9):1883-93.
8
Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.丙戊酸钠新型多单元缓释制剂的药代动力学特征
Int J Clin Pharmacol Ther. 1999 Feb;37(2):100-8.
9
Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.来自缓释氨茶碱制剂(优喘平缓释片)的茶碱生物利用度——单次和多次口服给药后的血浆水平
Int J Clin Pharmacol Ther Toxicol. 1981 May;19(5):223-7.
10
[Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].[耐胃液包衣双氯芬酸制剂的生物利用度。1. 与单单元制剂相比,多单元制剂单次给药后的生物利用度研究]
Arzneimittelforschung. 1993 Nov;43(11):1211-5.

引用本文的文献

1
Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets.盐酸甲氧氯普胺骨架片的制备及体外释放度比较。
Saudi Pharm J. 2009 Oct;17(4):283-8. doi: 10.1016/j.jsps.2009.10.004. Epub 2009 Nov 10.
2
Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects.甲氧氯普胺30毫克每日一次新型缓释片制剂与10毫克速释片的药代动力学比较:一项在健康男性受试者中进行的单剂量和多剂量、随机、开放标签、平行研究。
Eur J Drug Metab Pharmacokinet. 2012 Dec;37(4):279-88. doi: 10.1007/s13318-012-0082-0. Epub 2012 Feb 11.
3
Pharmacokinetic optimisation of antiemetic therapy.止吐疗法的药代动力学优化
Clin Pharmacokinet. 1992 Aug;23(2):147-60. doi: 10.2165/00003088-199223020-00006.